EXELIXIS HO.RE.CA
Exelixis serves channels of the consumer goods market and offers logistics services and commercial development, their services include enterprise resource planning system, customer relationship management, wireless warehouse management system, ordering system.
EXELIXIS HO.RE.CA
Industry:
CRM Enterprise Resource Planning (ERP) Logistics Trading Platform Warehousing
Founded:
2005-01-01
Address:
Thessaloníki, Thessaloniki, Greece
Country:
Greece
Website Url:
http://www.exelixis-horeca.gr
Total Employee:
101+
Status:
Active
Contact:
+30 231 072 3530
Email Addresses:
[email protected]
Official Site Inspections
http://www.exelixis-horeca.gr Semrush global rank: 6.81 M Semrush visits lastest month: 772
- Host name: 104.21.55.33
- IP address: 104.21.55.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Exelixis Ho.Re.Ca"
Shaping the Future of Oncology for Patients l Exelixis
At Exelixis, cancer is our cause. Over the course of the past three decades, we’ve evolved into a multi-platform cancer company dedicated to creating treatment regimens that challenge the …See details»
Exelixis - Wikipedia
Exelixis, Inc. is a genomics -based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration …See details»
Exelixis Medical Affairs | Exelixis, Inc
Learn about Exelixis Medical Affairs and how we improve patient outcomes in our clinical trials through innovation, communication, and research.See details»
Investors and News | Exelixis
Jul 14, 2025 Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine …See details»
Exelixis plans shuttering of East Coast site, 130 layoffs
Aug 29, 2025 UPDATED: Exelixis to lay off 130 employees, shut down Pennsylvania site in post-pandemic downsizing By Darren Incorvaia Aug 29, 2025 9:15am Exelixis biotech layoffs …See details»
Cancer Clinical Trials and Pipeline l Exelixis
* Sairopa B.V. (Sairopa) and Exelixis have an exclusive clinical development and option agreement providing Exelixis the right to acquire ADU-1805 ** Merck is sponsoring the study, …See details»
Exelixis | NeuroendocrineCancer
Exelixis is innovating at the forefront of cancer care. Their comprehensive approach is powered by a broad array of diverse biotherapeutics and small molecule programs for the treatment of …See details»
Spatially organized lymphocytic microenvironments in high
4 days ago The spatial organization and composition of the tumor-immune microenvironment (TME) play a critical role in shaping the progression of many solid cancers, but the …See details»
Nivolumab plus relatlimab and nivolumab plus ipilimumab for …
CHL reports consulting or advisory roles with Amgen, BMS, Exelixis, Eisai, Merck, Pfizer, and EMD Serono; honoraria from AiCME, Intellisphere, and Research to Practice; grants …See details»
Building a Legacy of Oncology Excellence l Exelixis
Exelixis is derived from Exelixi, the Greek word for evolution – an apt name reflecting the company’s growth from a functional genomics startup to a fully integrated biopharmaceutical …See details»